Table 7.
Clinical characteristics of patients enrolled in the two study groups undergoing more than one IVF cycle.
| Characteristic | IVF (n = 10) |
Ac + IVF (n = 8) |
p-Value | |
|---|---|---|---|---|
| Age (y) | 40.43 ± 3.87 | 37.88 ± 3.87 | p = 0.3096 | |
| BMI (kg/m2) | 24.19 ± 4.16 | 20.69 ± 2.99 | p = 0.1672 | |
| Duration of infertility (months) | 43.43 ± 37.84 | 33.25 ± 27.06 | p = 0.5305 | |
| Number of COH cycles | 3.86 ± 2.12 | 3.38 ± 1.92 | p = 0.3797 | |
| Hormone (Basal level) |
FSH (mIU/mL) | 10.45 ± 9.35 | 17.62 ± 16.69 | p = 0.1911 |
| LH (mIU/mL) | 1.68 ± 1.10 | 7.74 ± 8.63 | p = 0.0542 | |
| E2 (pg/mL) | 54.17 ± 18.94 | 120.86 ± 69.47 | p = 0.2359 | |
| TSH (µIU/mL) | 2.89 ± 1.53 | 2.19 ± 0.89 | p = 0.8884 | |
| DHEAS (µg/dL) | 141.37 ± 63.23 | 202.49 ± 144.60 | p = 0.5414 | |
| PRL (ng/mL) | 8.74 ± 3.38 | 9.27 ± 5.07 | p = 0.6730 | |
| AMH (ng/mL) | 0.39 ± 0.40 | 0.58 ± 0.44 | p = 0.2890 | |
| Antral follicle count (Basal level) | 3.71 ± 1.25 | 3.63 ± 0.92 | p = 0.6830 | |
Values are shown as mean ± standard deviation. Groups are compared using Wilcoxon rank-sum test. IVF, in vitro fertilization; Ac + IVF, combination of acupuncture and IVF treatment; COH, controlled ovulation hyperstimulation; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; TSH, thyroid stimulating hormone; DHEAS, dehydroisoandrosterone sulfate; PRL, prolactin; AMH, Anti-Müllerian hormone.